Preliminary experiments point out conolidine may inhibit certain ion channels, lessening neuronal excitability and restricting discomfort indicators. This mechanism is particularly suitable in neuropathic agony, wherever irregular signaling triggers persistent soreness. Additionally, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to discomfort perceptio... https://frankg147njd5.wikifrontier.com/user